Current development of 5-nitrofuran-2-yl derivatives as antitubercular agents
[Display omitted] Pulmonary tuberculosis (TB) is an infectious disease caused by Mycobacterium tuberculosis (MTB) and still remains one of the foremost fatal infectious diseases, infecting nearly a third of the worldwide population. The emergencies of multidrug-resistant and extensively drug-resista...
Saved in:
| Published in | Bioorganic chemistry Vol. 88; p. 102969 |
|---|---|
| Main Authors | , , |
| Format | Journal Article |
| Language | English |
| Published |
United States
Elsevier Inc
01.07.2019
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | [Display omitted]
Pulmonary tuberculosis (TB) is an infectious disease caused by Mycobacterium tuberculosis (MTB) and still remains one of the foremost fatal infectious diseases, infecting nearly a third of the worldwide population. The emergencies of multidrug-resistant and extensively drug-resistant tuberculosis (MDR and XDR-TB) prompt the efforts to deliver potent and novel anti-TB drugs. Research aimed at the development of new anti-TB drugs based on nitrofuran scaffold led to the identification of several candidates that were effective against actively growing as well as latent mycobacteria with unique modes of action. This review focuses on the recent advances in nitrofurans that could provide intriguing potential leads in the area of anti-TB drug discovery. |
|---|---|
| AbstractList | Pulmonary tuberculosis (TB) is an infectious disease caused by Mycobacterium tuberculosis (MTB) and still remains one of the foremost fatal infectious diseases, infecting nearly a third of the worldwide population. The emergencies of multidrug-resistant and extensively drug-resistant tuberculosis (MDR and XDR-TB) prompt the efforts to deliver potent and novel anti-TB drugs. Research aimed at the development of new anti-TB drugs based on nitrofuran scaffold led to the identification of several candidates that were effective against actively growing as well as latent mycobacteria with unique modes of action. This review focuses on the recent advances in nitrofurans that could provide intriguing potential leads in the area of anti-TB drug discovery. [Display omitted] Pulmonary tuberculosis (TB) is an infectious disease caused by Mycobacterium tuberculosis (MTB) and still remains one of the foremost fatal infectious diseases, infecting nearly a third of the worldwide population. The emergencies of multidrug-resistant and extensively drug-resistant tuberculosis (MDR and XDR-TB) prompt the efforts to deliver potent and novel anti-TB drugs. Research aimed at the development of new anti-TB drugs based on nitrofuran scaffold led to the identification of several candidates that were effective against actively growing as well as latent mycobacteria with unique modes of action. This review focuses on the recent advances in nitrofurans that could provide intriguing potential leads in the area of anti-TB drug discovery. |
| ArticleNumber | 102969 |
| Author | Mohamed, Malik Suliman Mohamed, Magdi A. Elsaman, Tilal |
| Author_xml | – sequence: 1 givenname: Tilal surname: Elsaman fullname: Elsaman, Tilal email: telbashir@ju.edu.sa organization: Department of Pharmaceutical Chemistry, College of Pharmacy, Jouf University, Sakaka, Saudi Arabia – sequence: 2 givenname: Malik Suliman surname: Mohamed fullname: Mohamed, Malik Suliman organization: Department of Pharmaceutics, College of Pharmacy, Jouf University, Sakaka, Saudi Arabia – sequence: 3 givenname: Magdi A. surname: Mohamed fullname: Mohamed, Magdi A. organization: Department of Pharmaceutical Chemistry, College of Pharmacy, Jouf University, Sakaka, Saudi Arabia |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31077910$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kE1LxDAURYMozof-A5Eu3XR8SdO02Qgy-AUjbnQd0vZlyNA2Y9IW5t_boaNL4UEe4dxcchbkvHUtEnJDYUWBivvdqrDO-e2KAZXjFZNCnpE5BQkxowzOyRyApzEDkc_IIoQdAKU8E5dkllDIMklhTt7XvffYdlGFA9Zu3xx3Z6I0bm3nnem9bmMWH-oR8HbQnR0wRHqctrNdX6Av-1r7SG_HYLgiF0bXAa9P55J8PT99rl_jzcfL2_pxE5eJYF2cZyBkknINVZlWWifAM6YznkpAFIJxqgvDZC4EYsENzQvNjWFVwhKtuTTJktxN7-69--4xdKqxocS61i26PijGEipZTlMYUT6hpXcheDRq722j_UFRUEeRaqcmkeooUk0ix9jtqaEvGqz-Qr_mRuBhAnD852DRq1BabEusrMeyU5Wz_zf8AMJAh-E |
| CitedBy_id | crossref_primary_10_3390_molecules28135284 crossref_primary_10_1371_journal_ppat_1009663 crossref_primary_10_3390_biom13081174 crossref_primary_10_3390_molecules28062529 crossref_primary_10_1016_j_ejmech_2020_112352 crossref_primary_10_3390_ph15091136 crossref_primary_10_1134_S1070328420060056 crossref_primary_10_1016_j_biortech_2021_125577 crossref_primary_10_1155_2023_1481595 crossref_primary_10_2174_0115734080266495231208045622 crossref_primary_10_1134_S003602362270005X crossref_primary_10_1039_D1RA08555G crossref_primary_10_3390_biom10010009 crossref_primary_10_1039_D3NJ01907A crossref_primary_10_1002_ardp_202200472 crossref_primary_10_1016_j_molstruc_2023_136155 crossref_primary_10_1002_slct_202200921 crossref_primary_10_3390_M1515 crossref_primary_10_1080_21505594_2020_1770508 crossref_primary_10_2174_1573406416666200619114124 crossref_primary_10_3390_antibiotics12010061 crossref_primary_10_3390_molecules29133071 |
| Cites_doi | 10.1016/j.bmc.2011.07.035 10.1016/j.ejmech.2018.08.068 10.1016/j.bmcl.2017.05.013 10.1016/j.bmcl.2010.08.127 10.1016/j.bmc.2018.03.004 10.4155/fmc-2018-0112 10.1021/acsmedchemlett.5b00141 10.1016/j.bmcl.2007.07.027 10.1093/jac/dkn307 10.1093/jac/35.6.751 10.1016/j.bmcl.2007.09.048 10.1016/j.ejmech.2010.07.020 10.1093/jac/46.6.917 10.1016/S0968-0896(01)00310-8 10.1016/j.pupt.2017.11.006 10.1016/j.ejmech.2010.11.023 10.1016/j.jegh.2011.10.001 10.2174/1381612043383214 10.3998/ark.5550190.p008.690 10.1016/j.bmcl.2017.07.023 10.1016/j.ejmech.2017.06.051 10.1016/j.bmcl.2018.12.053 10.1208/s12248-008-9017-8 10.1016/j.bmc.2017.02.003 10.1016/j.ejmech.2018.03.016 10.1016/j.bmc.2012.08.023 10.1016/j.bmcl.2013.10.010 10.1016/j.bjbas.2017.07.005 10.1016/j.ejmech.2017.05.057 10.1177/2040622315582325 10.1371/journal.pone.0087909 10.1021/jm049972y 10.1016/j.ejmech.2010.04.027 10.1128/AAC.47.8.2685-2687.2003 10.1093/jac/dkv147 10.1016/j.bmcl.2010.06.096 10.1016/j.bmcl.2018.07.046 10.1016/j.bmcl.2006.02.048 10.1248/bpb.b15-00439 10.1093/cid/cir889 10.1021/jm050765n 10.1016/j.ejmech.2015.05.007 10.1007/s00284-012-0176-6 10.1016/j.bmcl.2016.05.088 10.2174/156802607780059772 10.1016/j.bmcl.2008.12.088 |
| ContentType | Journal Article |
| Copyright | 2019 Elsevier Inc. Copyright © 2019 Elsevier Inc. All rights reserved. |
| Copyright_xml | – notice: 2019 Elsevier Inc. – notice: Copyright © 2019 Elsevier Inc. All rights reserved. |
| DBID | NPM AAYXX CITATION 7X8 |
| DOI | 10.1016/j.bioorg.2019.102969 |
| DatabaseName | PubMed CrossRef MEDLINE - Academic |
| DatabaseTitle | PubMed CrossRef MEDLINE - Academic |
| DatabaseTitleList | PubMed |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Anatomy & Physiology Chemistry |
| EISSN | 1090-2120 |
| EndPage | 102969 |
| ExternalDocumentID | 10_1016_j_bioorg_2019_102969 31077910 S0045206819303815 |
| Genre | Journal Article Review |
| GroupedDBID | --- --K --M -DZ -~X .GJ .~1 0R~ 1B1 1RT 1~. 1~5 23N 4.4 457 4G. 53G 5GY 5VS 7-5 71M 8P~ 9JM 9JN AAAJQ AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AARKO AARLI AATCM AAXUO ABEFU ABGSF ABJNI ABMAC ABUDA ABXDB ABYKQ ABZDS ACDAQ ACGFS ACNCT ACNNM ACRLP ADBBV ADECG ADEZE ADFGL ADMUD ADUVX AEBSH AEHWI AEKER AENEX AFKWA AFTJW AFXIZ AFZHZ AGEKW AGHFR AGRDE AGUBO AGYEJ AHHHB AIEXJ AIKHN AITUG AJBFU AJOXV AJSZI ALCLG ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC CAG CJTIS COF CS3 DM4 DOVZS DU5 EBS EFBJH EFLBG EJD EO8 EO9 EP2 EP3 F5P FA8 FDB FEDTE FGOYB FIRID FLBIZ FNPLU FYGXN G-2 G-Q GBLVA HLW HMG HMS HMT HVGLF HZ~ H~9 IHE J1W K-O KOM LG5 LUGTX LX2 LZ5 M2Y M33 M41 MO0 MVM N9A O-L O9- OAUVE OGGZJ OZT P-8 P-9 P2P PC. Q38 R2- RIG RNS ROL RPZ SBG SCB SDF SDG SDP SES SEW SIN SOC SPC SPCBC SPT SSI SSK SSP SSU SSZ T5K UQL WH7 WUQ XPP ZGI ZMT ~G- ~KM AAXKI AFJKZ AKRWK NPM AAYXX CITATION 7X8 |
| ID | FETCH-LOGICAL-c362t-87069354a0dc5daa30472a74590ee66241abf29866eeb4f18ba4ff2d323aa49f3 |
| IEDL.DBID | .~1 |
| ISSN | 0045-2068 |
| IngestDate | Sat Aug 17 03:57:22 EDT 2024 Thu Sep 26 18:16:52 EDT 2024 Sat Sep 28 08:27:47 EDT 2024 Fri Feb 23 02:51:07 EST 2024 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | Tuberculosis (TB) Structure-Activity Relationships (SARs) 5-Nitrofuran |
| Language | English |
| License | Copyright © 2019 Elsevier Inc. All rights reserved. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c362t-87069354a0dc5daa30472a74590ee66241abf29866eeb4f18ba4ff2d323aa49f3 |
| Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 |
| PMID | 31077910 |
| PQID | 2231928150 |
| PQPubID | 23479 |
| PageCount | 1 |
| ParticipantIDs | proquest_miscellaneous_2231928150 crossref_primary_10_1016_j_bioorg_2019_102969 pubmed_primary_31077910 elsevier_sciencedirect_doi_10_1016_j_bioorg_2019_102969 |
| PublicationCentury | 2000 |
| PublicationDate | July 2019 2019-07-00 20190701 |
| PublicationDateYYYYMMDD | 2019-07-01 |
| PublicationDate_xml | – month: 07 year: 2019 text: July 2019 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Bioorganic chemistry |
| PublicationTitleAlternate | Bioorg Chem |
| PublicationYear | 2019 |
| Publisher | Elsevier Inc |
| Publisher_xml | – name: Elsevier Inc |
| References | Feng, Liu, Wang, Chai, Hao, Meng, Guo (b0050) 2010; 45 Abdel-Aziz, Eldehna, Fares, Elsaman, Abdel-Aziz, Soliman (b0210) 2015; 38 Rakesh, Bruhn, Madhura, Maddox, Lee, Trivedi, Yang, Scherman, Gilliland, Gruppo, McNeil, Lenaerts, Meibohm (b0290) 2012; 20 Global Tuberculosis Report, WHO Report 2018, Geneva, 2018. Kamal, Ahmed, Reddy, Khan, Shetty, Siddhardha, Murthy, Khan, Kumar, Sharma, Ram (b0175) 2007; 17 Aboul-Fadl, Abdel-Hamid, Youssef (b0205) 2015; 7 Wang, Li, Wang, Lv, Wang, Liu, Guo, Lu (b0275) 2018; 10 Magotraa, Sharma, Singh, Ojhad, Kumarb, Bokoliac, Wazira, Sharma, Khan, Singh, Vishwakarmaf, Singha, Nandia (b0270) 2018; 48 E.V. Verbitskiy, S.A. Baskakova, N.A. Gerasimova, N.P. Evstigneeva, N.V. Zil’berberg, N.V. Kungurov, M.A. Kravchenko, G.L. Rusinov, O.N. Chupakhin, V.N. Charushin, New 5-arylamino-4-(5-nitrofuran-2-yl)pyrimidines as Promising Antibacterial Agents. Mendeleev Commun. 28 (2018) 393–395. Murugasu-Oei, Dick (b0160) 2000; 46 Mandewale, Patil, Shedge, Dappadwad, Yamgar (b0305) 2017; 6 Wang, Yang, Jun, Wang, Lv, Liu, Guo, Lu (b0265) 2018; 26 Kamal, Hussaini, Faazil, Poornachandra, Reddy, Kumar, Rajput, Rani, Sharma, Khan, Jagadeesh Babu (b0195) 2013; 23 Krasavin, Parchinsky, Kantin, Manicheva, Dogonadze, Vinogradova, Karge, Brönstrup (b0225) 2017; 25 Fana, Wua, Kea, Huang (b0250) 2018; 28 Tangallapally, Yendapally, Lee, Lenaerts, Lee (b0105) 2005; 48 Ran, Gao, Deng, Lei, You, Wanga, Shi, Liu, Wei, Peng, Xiong, Xiao, Yu (b0220) 2016; 26 Xu, Zhang, Song, Qiang, Lv (b0235) 2017; 27 Yempalla, Munagala, Singh, Magotra, Kumar, Rajput, Bharate, Tikoo, Singh, Khan, Vishwakarma, Singh (b0260) 2015; 6 Smith, Edwards (b0150) 1995; 44 Bermudez, Reynolds, Kolonoski, Aralar, Inderlied, Young (b0070) 2003; 47 Tangallapally, Lee, Lenaerts, Lee (b0115) 2006; 16 Rakesh, Bruhn, Scherman, Woolhiser, Madhura, Maddox, Singh, Lee, Hurdle, McNeil, Lenaerts, Meibohm, Lee (b0120) 2014; 9 T. Aboul-Fadl. Isatin Derivatives and their use in Therapy, 2013, Patent EP 2 604 600 A1. Krasavin, Lukin, Vedekhina, Manicheva, Dogonadze, Vinogradova, Zabolotnykh, Rogacheva, Kraeva, Yablonsky (b0285) 2018; 157 Tangallapally, Yendapally, Lee, Lenaerts, Lee (b0110) 2004; 47 Zhang, Xu, Gao, Ren, Chang, Lv, Feng (b0190) 2017; 138 Global Tuberculosis Report, WHO Report 2014, Geneva, 2014. Fan, Jin, Huang, Yu, Zeng, Gao, Feng (b0280) 2018; 150 Tawari, Bairwa, Ray, Rajan, Degani (b0185) 2010; 20 Hurdle, Lee, Budha, Carson, Qi, Scherman, Cho, McNeil, Lenaerts, Franzblau, Meibohm, Lee (b0145) 2008; 62 Xu, Song, Hu, Qiang, Lv (b0230) 2017; 138 Gallardo-Macias, Kumar, Jaskowski, Richmann, Shrestha, Russo, Singleton, Zimmerman, Ho, Dartois, Connell, Alland, Freundlich (b0300) 2019 Field (b0045) 2015; 6 J.Crofton, P. Chaulet, D. Maher, Guidelines for the Management of Drug- resistant Tuberculosis: WHO/TB/96-210 (Rev. 1), World Health Organization, Geneva, 1997. Barry, Boshoff, Dowd (b0155) 2004; 10 Udwadia, Amale, Ajbani, Rodrigues (b0035) 2012; 54 Jordao, Sathler, Ferreira, Campos, de Souza, Castro, Lannes, Lourenco, Rodrigues, Bello, Lourenco, Carvalho, Almeida, Cunha (b0215) 2011; 19 Global Tuberculosis Report, WHO Report 2015, Geneva, 2015. Cocco, Congiu, Onnis, Pellerano, De Logu (b0065) 2002; 10 Verbitskiy, Cheprakova, Slepukhin, Kravchenko, Skornyakov, Rusinov, Chupakhin, Charushin (b0085) 2015 Sriram, Yogeeswari, Vyas, Senthilkumar, Bhat, Srividya (b0180) 2010; 20 Ugwu, Ezema, Eze, Ugwuja (b0005) 2014; 2014 WHO, A guide to monitoring and evaluation for collaborative TB/HIV activities, 2015. Aboul-Fadl, Bin-Jubair, Aboul-Wafa (b0055) 2010; 45 Huttner, Verhaegh, Harbarth, Muller, Theuretzbacher, Mouton (b0165) 2015; 70 Verbitskiy, Toporova, Kodess, Ezhikova, Isenov, Pervova, Kravchenko, Medvinskiy, Skornyakov, Rusinov, Charushina (b0090) 2014; 5 Tangallapally, Sun, Rakesh, Lee (b0135) 2007; 17 Santos, Castro, Lourenco, Abreu, Batalha, Cunha, Carvalho, Rodrigues, Medeiros, Souza, Ferreira (b0310) 2012; 65 Verbitskiy, Baskakova, Gerasimova, Evstigneeva, Zil’berberg, Kungurov, Kravchenko, Skornyakov, Pervova, Rusinov, Chupakhin, Charushin (b0095) 2017; 27 R. Petrovanu, O. Leonte, In vitro antimicrobial effect of some benzylamine and thienylamine derivatives, Analele Stiintifice ale Universitatii AI I Cuza din Iasi, Sectiunea 1c Chimie. 13 (1967) 153–156. Sriram, Yogeeswari, Dhakla, Senthilkumar, Banerjee, Manjashetty (b0170) 2009; 19 Gupta, Kaskhedikar (b0255) 2012; 5 Budha, Mehrotra, Tangallapally, Jianjun Qi, Daniels, Lee, Meibohm (b0125) 2008; 10 Feng, Liu, Zhang, Chai, Wang, Zhang, Lv, Guan, Guo, Xiao (b0240) 2011; 46 Tangallapally, Yendapally, Daniels, Lee, Lee (b0140) 2007; 7 Asif (b0075) 2013; 9 Chaudhry, Rambhala, Al-Shammri, Al-Tawfiq (b0040) 2012; 2 Global Tuberculosis Report, WHO Report 2013, Geneva, 2013. Rakesh, Madhura, Maddox, Lee, Trivedi, Yang, Scherman, Gilliland, Gruppo, McNeil, Lenaerts, Meibohm, Lee (b0130) 2012; 20 W. Tiasheng, H. Brian, M. Ute, B. Guy, H.J. Zuccola, Pyrimidine Compounds as Tuberculosis Inhibitors, 2010, Patent WO2011019405A1. Feng, Liu, Wang, Chai, Hao, Meng, Guo (b0245) 2010; 45 Feng (10.1016/j.bioorg.2019.102969_b0050) 2010; 45 Rakesh (10.1016/j.bioorg.2019.102969_b0120) 2014; 9 Xu (10.1016/j.bioorg.2019.102969_b0230) 2017; 138 Ugwu (10.1016/j.bioorg.2019.102969_b0005) 2014; 2014 Murugasu-Oei (10.1016/j.bioorg.2019.102969_b0160) 2000; 46 Krasavin (10.1016/j.bioorg.2019.102969_b0225) 2017; 25 10.1016/j.bioorg.2019.102969_b0020 10.1016/j.bioorg.2019.102969_b0100 Tangallapally (10.1016/j.bioorg.2019.102969_b0140) 2007; 7 10.1016/j.bioorg.2019.102969_b0025 Tawari (10.1016/j.bioorg.2019.102969_b0185) 2010; 20 Tangallapally (10.1016/j.bioorg.2019.102969_b0115) 2006; 16 Hurdle (10.1016/j.bioorg.2019.102969_b0145) 2008; 62 Gallardo-Macias (10.1016/j.bioorg.2019.102969_b0300) 2019 10.1016/j.bioorg.2019.102969_b0030 Sriram (10.1016/j.bioorg.2019.102969_b0170) 2009; 19 Barry (10.1016/j.bioorg.2019.102969_b0155) 2004; 10 Feng (10.1016/j.bioorg.2019.102969_b0245) 2010; 45 Zhang (10.1016/j.bioorg.2019.102969_b0190) 2017; 138 Yempalla (10.1016/j.bioorg.2019.102969_b0260) 2015; 6 Asif (10.1016/j.bioorg.2019.102969_b0075) 2013; 9 10.1016/j.bioorg.2019.102969_b0010 10.1016/j.bioorg.2019.102969_b0295 Mandewale (10.1016/j.bioorg.2019.102969_b0305) 2017; 6 Bermudez (10.1016/j.bioorg.2019.102969_b0070) 2003; 47 10.1016/j.bioorg.2019.102969_b0015 Tangallapally (10.1016/j.bioorg.2019.102969_b0135) 2007; 17 Field (10.1016/j.bioorg.2019.102969_b0045) 2015; 6 Sriram (10.1016/j.bioorg.2019.102969_b0180) 2010; 20 10.1016/j.bioorg.2019.102969_b0060 Feng (10.1016/j.bioorg.2019.102969_b0240) 2011; 46 Aboul-Fadl (10.1016/j.bioorg.2019.102969_b0055) 2010; 45 Jordao (10.1016/j.bioorg.2019.102969_b0215) 2011; 19 Wang (10.1016/j.bioorg.2019.102969_b0265) 2018; 26 Verbitskiy (10.1016/j.bioorg.2019.102969_b0085) 2015 Wang (10.1016/j.bioorg.2019.102969_b0275) 2018; 10 Huttner (10.1016/j.bioorg.2019.102969_b0165) 2015; 70 10.1016/j.bioorg.2019.102969_b0200 Fan (10.1016/j.bioorg.2019.102969_b0280) 2018; 150 Fana (10.1016/j.bioorg.2019.102969_b0250) 2018; 28 Smith (10.1016/j.bioorg.2019.102969_b0150) 1995; 44 Krasavin (10.1016/j.bioorg.2019.102969_b0285) 2018; 157 Tangallapally (10.1016/j.bioorg.2019.102969_b0110) 2004; 47 Aboul-Fadl (10.1016/j.bioorg.2019.102969_b0205) 2015; 7 Xu (10.1016/j.bioorg.2019.102969_b0235) 2017; 27 Udwadia (10.1016/j.bioorg.2019.102969_b0035) 2012; 54 Tangallapally (10.1016/j.bioorg.2019.102969_b0105) 2005; 48 Kamal (10.1016/j.bioorg.2019.102969_b0175) 2007; 17 Rakesh (10.1016/j.bioorg.2019.102969_b0130) 2012; 20 Santos (10.1016/j.bioorg.2019.102969_b0310) 2012; 65 Cocco (10.1016/j.bioorg.2019.102969_b0065) 2002; 10 Ran (10.1016/j.bioorg.2019.102969_b0220) 2016; 26 Kamal (10.1016/j.bioorg.2019.102969_b0195) 2013; 23 Budha (10.1016/j.bioorg.2019.102969_b0125) 2008; 10 Chaudhry (10.1016/j.bioorg.2019.102969_b0040) 2012; 2 Rakesh (10.1016/j.bioorg.2019.102969_b0290) 2012; 20 10.1016/j.bioorg.2019.102969_b0080 Verbitskiy (10.1016/j.bioorg.2019.102969_b0090) 2014; 5 Magotraa (10.1016/j.bioorg.2019.102969_b0270) 2018; 48 Abdel-Aziz (10.1016/j.bioorg.2019.102969_b0210) 2015; 38 Gupta (10.1016/j.bioorg.2019.102969_b0255) 2012; 5 Verbitskiy (10.1016/j.bioorg.2019.102969_b0095) 2017; 27 |
| References_xml | – volume: 10 start-page: 501 year: 2002 end-page: 506 ident: b0065 article-title: Synthesis and antimycobacterial activity of new S-alkylisothiosemicarbazone derivatives publication-title: Bioorg. Med. Chem. contributor: fullname: De Logu – volume: 23 start-page: 6842 year: 2013 end-page: 6846 ident: b0195 article-title: Anti-tubercular Agents. Part 8: synthesis, antibacterial and antitubercular activity of 5-nitrofuran based 1,2,3-triazoles publication-title: Bioorg. Med. Chem. Lett. contributor: fullname: Jagadeesh Babu – volume: 25 start-page: 1867 year: 2017 end-page: 1874 ident: b0225 article-title: New nitrofurans amenable by isocyanide multicomponent chemistry are active against multidrug-resistant and poly-resistant publication-title: Bioorg. Med. Chem. contributor: fullname: Brönstrup – volume: 10 start-page: 3239 year: 2004 end-page: 3269 ident: b0155 article-title: Prospects for clinical introduction of nitroimidazole antibiotics for the treatment of tuberculosis publication-title: Curr. Pharm. Des. contributor: fullname: Dowd – volume: 65 start-page: 455 year: 2012 end-page: 460 ident: b0310 article-title: Finding a new potential antimycobacterium derivative in a aldehyde–arylhydrazone–oxoquinoline series publication-title: Curr. Microbiol. contributor: fullname: Ferreira – volume: 10 start-page: 2059 year: 2018 end-page: 2068 ident: b0275 article-title: Synthesis and evaluation of nitrofuranyl methyl n-heterocycles derivatives as novel antitubercular agents publication-title: Future Med. Chem. contributor: fullname: Lu – volume: 28 start-page: 3064 year: 2018 end-page: 3066 ident: b0250 article-title: Design, synthesis and evaluation of oxime-functionalized nitrofuranylamides as novel antitubercular agents publication-title: Bioorg. Med. Chem. Lett. contributor: fullname: Huang – volume: 47 start-page: 5276 year: 2004 end-page: 5283 ident: b0110 article-title: Synthesis of nitrofuranyl amides as novel antituberculosis agents publication-title: J. Med. Chem. contributor: fullname: Lee – volume: 26 start-page: 3669 year: 2016 end-page: 3674 ident: b0220 article-title: Identification of novel 2-aminothiazole conjugated nitrofuran as antitubercular and antibacterial agents publication-title: Bioorg. Med. Chem. Lett. contributor: fullname: Yu – volume: 70 start-page: 2456 year: 2015 end-page: 2464 ident: b0165 publication-title: J. Antimicrob. Chemother. contributor: fullname: Mouton – volume: 150 start-page: 347 year: 2018 end-page: 365 ident: b0280 article-title: Recent advances of imidazole-containing derivatives as anti-tubercular agents publication-title: Eur. J. Med. Chem. contributor: fullname: Feng – year: 2019 ident: b0300 article-title: Optimization of N-benzyl-5-nitrofuran-2-carboxamide as an antitubercular agent publication-title: Bioorg. Med. Chem. Lett. contributor: fullname: Freundlich – volume: 17 start-page: 6638 year: 2007 end-page: 6642 ident: b0135 article-title: Discovery of novel isoxazolines as anti-tuberculosis agents publication-title: Bioorg. Med. Chem. Lett. contributor: fullname: Lee – volume: 9 start-page: 180 year: 2013 end-page: 218 ident: b0075 article-title: Some recent approaches in the design of synthetic anti-tubercular agents containing five membered heterocycles rings publication-title: OCAIJ contributor: fullname: Asif – volume: 5 start-page: 251 year: 2012 end-page: 259 ident: b0255 article-title: Synthesis, evaluation and QSAR analysis of 5-nitrofuran-2-yl/4-nitrophenyl methylene substituted hydrazides as antitubercular agents publication-title: Asian J. Pharm. Clin. Res. contributor: fullname: Kaskhedikar – volume: 2014 start-page: 1 year: 2014 end-page: 18 ident: b0005 article-title: Synthesis and structural activity relationship study of antitubercular carboxamides publication-title: Int. J. Med. Chem. contributor: fullname: Ugwuja – volume: 10 start-page: 157 year: 2008 end-page: 165 ident: b0125 article-title: Pharmacokinetically guided lead optimization of nitrofuranylamide anti-tuberculosis agents publication-title: AAPSJ contributor: fullname: Meibohm – volume: 46 start-page: 917 year: 2000 end-page: 919 ident: b0160 article-title: Bactericidal activity of nitrofurans against growing and dormant publication-title: J. Antimicrob. Chemother. contributor: fullname: Dick – volume: 45 start-page: 3407 year: 2010 end-page: 3412 ident: b0245 article-title: Synthesis and in vitro antimycobacterial activity of balofloxacin-ethylene-isatin derivatives publication-title: Eur. J. Med. Chem. contributor: fullname: Guo – volume: 27 start-page: 3003 year: 2017 end-page: 3006 ident: b0095 article-title: Synthesis and biological evaluation of novel 5-aryl-4-(5-nitrofuran-2-yl)-pyrimidines as potential anti-bacterial agents publication-title: Bioorg. Med. Chem. Lett. contributor: fullname: Charushin – volume: 19 start-page: 1152 year: 2009 end-page: 1154 ident: b0170 article-title: 5-Nitrofuran-2-yl derivatives: synthesis and inhibitory activities against growing and dormant mycobacterium species publication-title: Bioorg. Med. Chem. Lett. contributor: fullname: Manjashetty – volume: 7 start-page: 509 year: 2007 end-page: 526 ident: b0140 article-title: Nitrofurans as novel anti-tuberculosis agents: identification, development and evaluation publication-title: Curr. Top. Med. Chem. contributor: fullname: Lee – volume: 20 start-page: 6063 year: 2012 end-page: 6072 ident: b0130 article-title: Antitubercular nitrofuran isoxazolines with improved pharmacokinetic properties publication-title: Bioorg. Med. Chem. contributor: fullname: Lee – volume: 44 start-page: 751 year: 1995 end-page: 764 ident: b0150 article-title: Redox potential and oxygen concentration as factors in the susceptibility of publication-title: J. Antimicorb. Chemother. contributor: fullname: Edwards – volume: 45 start-page: 3407 year: 2010 end-page: 3434 ident: b0050 article-title: Synthesis and in vitro antimycobacterial activity of balofloxacin ethylene isatin derivatives publication-title: Eur. J. Med. Chem. contributor: fullname: Guo – volume: 6 start-page: 354 year: 2017 end-page: 361 ident: b0305 article-title: A review on quinoline hydrazone derivatives as a new class of potent antitubercular and anticancer agents publication-title: Beni-Suef Univ. J. Basic Appl. Sci. contributor: fullname: Yamgar – volume: 16 start-page: 2584 year: 2006 end-page: 2589 ident: b0115 article-title: Discovery of novel isoxazolines as anti-tuberculosis agents publication-title: Bioorg. Med. Chem. Lett. contributor: fullname: Lee – volume: 138 start-page: 66 year: 2017 end-page: 71 ident: b0230 article-title: Azide-alkyne cycloaddition towards 1H–1,2,3-triazole tethered Gatifloxacin and Isatin conjugates: design, synthesis and in vitro anti-mycobacterial evaluation publication-title: Eur. J. Med. Chem. contributor: fullname: Lv – volume: 45 start-page: 4578 year: 2010 end-page: 4586 ident: b0055 article-title: Schiff Bases of indoline-2,3-dione (isatin) derivatives and nalidixic acid carbohydrazide, synthesis, antitubercular activity and pharmacophoric model building publication-title: Eur. J. Med. Chem. contributor: fullname: Aboul-Wafa – volume: 6 start-page: 1041 year: 2015 end-page: 1046 ident: b0260 article-title: Nitrofuranyl methyl piperazines as new anti-TB agents: identification, validation, medicinal chemistry and PK studies publication-title: ACS Med. Chem. Lett. contributor: fullname: Singh – volume: 48 start-page: 151 year: 2018 end-page: 160 ident: b0270 article-title: Physicochemical, pharmacokinetic, efficacy and toxicity profiling of a potential nitrofuranyl methyl piperazine derivative IIIM-MCD-211 for oral tuberculosis therapy via in-silico–in-vitro–in-vivo approach publication-title: Pulm. Pharmacol. Ther. contributor: fullname: Nandia – volume: 62 start-page: 1037 year: 2008 end-page: 1045 ident: b0145 article-title: A microbiological assessment of novel nitrofuranylamides as anti-tuberculosis agents publication-title: J. Antimicrob. Chemother. contributor: fullname: Lee – volume: 9 start-page: e87909 year: 2014 ident: b0120 article-title: Pentacyclic nitrofurans with in vivo efficacy and activity against nonreplicating publication-title: PLoS ONE contributor: fullname: Lee – volume: 2 start-page: 57 year: 2012 end-page: 60 ident: b0040 article-title: Patterns of antituberculous drug resistance in Eastern Saudi Arabia: a 7-year surveillance study from 1/2003 to 6/2010 publication-title: J. Epidemiol. Global. Health contributor: fullname: Al-Tawfiq – volume: 26 start-page: 2073 year: 2018 end-page: 2084 ident: b0265 article-title: Synthesis, evaluation and CoMFA/CoMSIA study of nitrofuranyl methyl N-heterocycles as novel antitubercular agents publication-title: Bioorg. Med. Chem. contributor: fullname: Lu – volume: 19 start-page: 5605 year: 2011 end-page: 5611 ident: b0215 article-title: Synthesis, antitubercular activity, and SAR Study of N-substituted-phenylamino-5-methyl-1H-1,2,3-triazole-4-carbohydrazides publication-title: Bioorg. Med. Chem. contributor: fullname: Cunha – volume: 7 start-page: 217 year: 2015 end-page: 225 ident: b0205 article-title: Schiff bases of indoline-2,3-dione (isatin) derivatives as efficient agents against resistant strains of publication-title: Der. Pharm. Chem contributor: fullname: Youssef – volume: 47 start-page: 2685 year: 2003 end-page: 2687 ident: b0070 article-title: Thiosemicarbazole (thiacetazone-like) compound with activity against publication-title: Antimicrob. Agents Chemother. contributor: fullname: Young – volume: 54 start-page: 579 year: 2012 end-page: 581 ident: b0035 article-title: Totally drug-resistant tuberculosis in India publication-title: Clin. Infect. Dis. contributor: fullname: Rodrigues – volume: 6 start-page: 170 year: 2015 end-page: 184 ident: b0045 article-title: Bedaquiline for the treatment of multidrug-resistant tuberculosis: great promise or disappointment? publication-title: Ther. Adv. Chronic. Dis. contributor: fullname: Field – volume: 27 start-page: 3643 year: 2017 end-page: 3646 ident: b0235 article-title: Design, synthesis and in vitro anti-mycobacterial evaluation of Gatifloxacin-1H-1,2,3-triazole-isatin hybrids publication-title: Bioorg. Med. Chem. Lett. contributor: fullname: Lv – volume: 38 start-page: 1617 year: 2015 end-page: 1630 ident: b0210 article-title: Synthesis, in vitro and in silico studies of some novel 5-nitrofuran-2-yl hydrazones as antimicrobial and antitubercular agents publication-title: Biol. Pharm. Bull. contributor: fullname: Soliman – volume: 157 start-page: 1115 year: 2018 end-page: 1126 ident: b0285 article-title: Conjugation of a 5-nitrofuran-2-oyl moiety to aminoalkylimidazoles produces non-toxic nitrofurans that are efficacious in vitro and in vivo against multidrug-resistant publication-title: Eur. J. Med. Chem. contributor: fullname: Yablonsky – volume: 20 start-page: 4313 year: 2010 end-page: 4316 ident: b0180 article-title: 5-Nitro-2-furoic acid hydrazones: design, synthesis and in vitro antimycobacterial evaluation against log and starved phase cultures publication-title: Bioorg. Med. Chem. Lett. contributor: fullname: Srividya – volume: 5 start-page: 247 year: 2014 end-page: 270 ident: b0090 article-title: Synthesis, X-ray crystal structure and antimycobacterial activity of enantiomerically pure 1-ethyl-2,3-dicyano-5-(het)aryl-6-hetaryl-1,6-dihydropyrazines publication-title: ARKIVOK contributor: fullname: Charushina – volume: 48 start-page: 8261 year: 2005 end-page: 8269 ident: b0105 article-title: Synthesis and evaluation of cyclic secondary amine substituted phenyl and benzyl nitrofuranyl amides as novel antituberculosis agents publication-title: J. Med. Chem. contributor: fullname: Lee – volume: 17 start-page: 5419 year: 2007 end-page: 5422 ident: b0175 article-title: Anti-tubercular agents. Part IV: synthesis and antimycobacterial evaluation of nitroheterocyclic-based 1,2,4-benzothiadiazines publication-title: Bioorg. Med. Chem. Lett. contributor: fullname: Ram – volume: 138 start-page: 501 year: 2017 end-page: 513 ident: b0190 article-title: Triazole derivatives and their anti-tubercular activity publication-title: Eu. J. Med. Chem. contributor: fullname: Feng – year: 2015 ident: b0085 article-title: Synthesis, and structure-activity relationship for C(4) and/or C(5) thienyl substituted pyrimidines, as a new family of antimycobacterial compounds publication-title: Eu. J. Med. Chem contributor: fullname: Charushin – volume: 20 start-page: 6063 year: 2012 end-page: 6072 ident: b0290 article-title: Antitubercular nitrofuran isoxazolines with improved pharmacokinetic properties publication-title: Bioorg. Med. Chem. contributor: fullname: Meibohm – volume: 46 start-page: 341 year: 2011 end-page: 348 ident: b0240 article-title: Synthesis and in vitro antimycobacterial activity of 8-OCH(3) ciprofloxacin methylene and ethylene isatin derivatives publication-title: Eur. J. Med. Chem. contributor: fullname: Xiao – volume: 20 start-page: 6175 year: 2010 end-page: 6178 ident: b0185 article-title: Design, synthesis, and biological evaluation of 4-(5-nitrofuran-2-yl)prop-2-en-1-one derivatives as potent antitubercular agents publication-title: Bioorg. Med. Chem. Lett. contributor: fullname: Degani – volume: 19 start-page: 5605 year: 2011 ident: 10.1016/j.bioorg.2019.102969_b0215 article-title: Synthesis, antitubercular activity, and SAR Study of N-substituted-phenylamino-5-methyl-1H-1,2,3-triazole-4-carbohydrazides publication-title: Bioorg. Med. Chem. doi: 10.1016/j.bmc.2011.07.035 contributor: fullname: Jordao – volume: 157 start-page: 1115 year: 2018 ident: 10.1016/j.bioorg.2019.102969_b0285 article-title: Conjugation of a 5-nitrofuran-2-oyl moiety to aminoalkylimidazoles produces non-toxic nitrofurans that are efficacious in vitro and in vivo against multidrug-resistant Mycobacterium tuberculosis publication-title: Eur. J. Med. Chem. doi: 10.1016/j.ejmech.2018.08.068 contributor: fullname: Krasavin – volume: 27 start-page: 3003 year: 2017 ident: 10.1016/j.bioorg.2019.102969_b0095 article-title: Synthesis and biological evaluation of novel 5-aryl-4-(5-nitrofuran-2-yl)-pyrimidines as potential anti-bacterial agents publication-title: Bioorg. Med. Chem. Lett. doi: 10.1016/j.bmcl.2017.05.013 contributor: fullname: Verbitskiy – volume: 20 start-page: 6175 year: 2010 ident: 10.1016/j.bioorg.2019.102969_b0185 article-title: Design, synthesis, and biological evaluation of 4-(5-nitrofuran-2-yl)prop-2-en-1-one derivatives as potent antitubercular agents publication-title: Bioorg. Med. Chem. Lett. doi: 10.1016/j.bmcl.2010.08.127 contributor: fullname: Tawari – volume: 2014 start-page: 1 year: 2014 ident: 10.1016/j.bioorg.2019.102969_b0005 article-title: Synthesis and structural activity relationship study of antitubercular carboxamides publication-title: Int. J. Med. Chem. contributor: fullname: Ugwu – volume: 26 start-page: 2073 year: 2018 ident: 10.1016/j.bioorg.2019.102969_b0265 article-title: Synthesis, evaluation and CoMFA/CoMSIA study of nitrofuranyl methyl N-heterocycles as novel antitubercular agents publication-title: Bioorg. Med. Chem. doi: 10.1016/j.bmc.2018.03.004 contributor: fullname: Wang – volume: 10 start-page: 2059 year: 2018 ident: 10.1016/j.bioorg.2019.102969_b0275 article-title: Synthesis and evaluation of nitrofuranyl methyl n-heterocycles derivatives as novel antitubercular agents publication-title: Future Med. Chem. doi: 10.4155/fmc-2018-0112 contributor: fullname: Wang – volume: 6 start-page: 1041 year: 2015 ident: 10.1016/j.bioorg.2019.102969_b0260 article-title: Nitrofuranyl methyl piperazines as new anti-TB agents: identification, validation, medicinal chemistry and PK studies publication-title: ACS Med. Chem. Lett. doi: 10.1021/acsmedchemlett.5b00141 contributor: fullname: Yempalla – volume: 17 start-page: 5419 year: 2007 ident: 10.1016/j.bioorg.2019.102969_b0175 article-title: Anti-tubercular agents. Part IV: synthesis and antimycobacterial evaluation of nitroheterocyclic-based 1,2,4-benzothiadiazines publication-title: Bioorg. Med. Chem. Lett. doi: 10.1016/j.bmcl.2007.07.027 contributor: fullname: Kamal – volume: 62 start-page: 1037 year: 2008 ident: 10.1016/j.bioorg.2019.102969_b0145 article-title: A microbiological assessment of novel nitrofuranylamides as anti-tuberculosis agents publication-title: J. Antimicrob. Chemother. doi: 10.1093/jac/dkn307 contributor: fullname: Hurdle – volume: 44 start-page: 751 year: 1995 ident: 10.1016/j.bioorg.2019.102969_b0150 article-title: Redox potential and oxygen concentration as factors in the susceptibility of Helicobacter Pylori to nitroheterocyclic drugs publication-title: J. Antimicorb. Chemother. doi: 10.1093/jac/35.6.751 contributor: fullname: Smith – volume: 17 start-page: 6638 year: 2007 ident: 10.1016/j.bioorg.2019.102969_b0135 article-title: Discovery of novel isoxazolines as anti-tuberculosis agents publication-title: Bioorg. Med. Chem. Lett. doi: 10.1016/j.bmcl.2007.09.048 contributor: fullname: Tangallapally – ident: 10.1016/j.bioorg.2019.102969_b0080 – volume: 45 start-page: 4578 year: 2010 ident: 10.1016/j.bioorg.2019.102969_b0055 article-title: Schiff Bases of indoline-2,3-dione (isatin) derivatives and nalidixic acid carbohydrazide, synthesis, antitubercular activity and pharmacophoric model building publication-title: Eur. J. Med. Chem. doi: 10.1016/j.ejmech.2010.07.020 contributor: fullname: Aboul-Fadl – volume: 46 start-page: 917 year: 2000 ident: 10.1016/j.bioorg.2019.102969_b0160 article-title: Bactericidal activity of nitrofurans against growing and dormant Mycobacterium Bovis BCG publication-title: J. Antimicrob. Chemother. doi: 10.1093/jac/46.6.917 contributor: fullname: Murugasu-Oei – volume: 10 start-page: 501 year: 2002 ident: 10.1016/j.bioorg.2019.102969_b0065 article-title: Synthesis and antimycobacterial activity of new S-alkylisothiosemicarbazone derivatives publication-title: Bioorg. Med. Chem. doi: 10.1016/S0968-0896(01)00310-8 contributor: fullname: Cocco – volume: 48 start-page: 151 year: 2018 ident: 10.1016/j.bioorg.2019.102969_b0270 article-title: Physicochemical, pharmacokinetic, efficacy and toxicity profiling of a potential nitrofuranyl methyl piperazine derivative IIIM-MCD-211 for oral tuberculosis therapy via in-silico–in-vitro–in-vivo approach publication-title: Pulm. Pharmacol. Ther. doi: 10.1016/j.pupt.2017.11.006 contributor: fullname: Magotraa – volume: 46 start-page: 341 year: 2011 ident: 10.1016/j.bioorg.2019.102969_b0240 article-title: Synthesis and in vitro antimycobacterial activity of 8-OCH(3) ciprofloxacin methylene and ethylene isatin derivatives publication-title: Eur. J. Med. Chem. doi: 10.1016/j.ejmech.2010.11.023 contributor: fullname: Feng – volume: 2 start-page: 57 year: 2012 ident: 10.1016/j.bioorg.2019.102969_b0040 article-title: Patterns of antituberculous drug resistance in Eastern Saudi Arabia: a 7-year surveillance study from 1/2003 to 6/2010 publication-title: J. Epidemiol. Global. Health. doi: 10.1016/j.jegh.2011.10.001 contributor: fullname: Chaudhry – volume: 10 start-page: 3239 year: 2004 ident: 10.1016/j.bioorg.2019.102969_b0155 article-title: Prospects for clinical introduction of nitroimidazole antibiotics for the treatment of tuberculosis publication-title: Curr. Pharm. Des. doi: 10.2174/1381612043383214 contributor: fullname: Barry – volume: 5 start-page: 247 year: 2014 ident: 10.1016/j.bioorg.2019.102969_b0090 article-title: Synthesis, X-ray crystal structure and antimycobacterial activity of enantiomerically pure 1-ethyl-2,3-dicyano-5-(het)aryl-6-hetaryl-1,6-dihydropyrazines publication-title: ARKIVOK doi: 10.3998/ark.5550190.p008.690 contributor: fullname: Verbitskiy – ident: 10.1016/j.bioorg.2019.102969_b0010 – volume: 27 start-page: 3643 year: 2017 ident: 10.1016/j.bioorg.2019.102969_b0235 article-title: Design, synthesis and in vitro anti-mycobacterial evaluation of Gatifloxacin-1H-1,2,3-triazole-isatin hybrids publication-title: Bioorg. Med. Chem. Lett. doi: 10.1016/j.bmcl.2017.07.023 contributor: fullname: Xu – volume: 138 start-page: 501 year: 2017 ident: 10.1016/j.bioorg.2019.102969_b0190 article-title: Triazole derivatives and their anti-tubercular activity publication-title: Eu. J. Med. Chem. doi: 10.1016/j.ejmech.2017.06.051 contributor: fullname: Zhang – year: 2019 ident: 10.1016/j.bioorg.2019.102969_b0300 article-title: Optimization of N-benzyl-5-nitrofuran-2-carboxamide as an antitubercular agent publication-title: Bioorg. Med. Chem. Lett. doi: 10.1016/j.bmcl.2018.12.053 contributor: fullname: Gallardo-Macias – ident: 10.1016/j.bioorg.2019.102969_b0295 – volume: 10 start-page: 157 year: 2008 ident: 10.1016/j.bioorg.2019.102969_b0125 article-title: Pharmacokinetically guided lead optimization of nitrofuranylamide anti-tuberculosis agents publication-title: AAPSJ doi: 10.1208/s12248-008-9017-8 contributor: fullname: Budha – volume: 25 start-page: 1867 year: 2017 ident: 10.1016/j.bioorg.2019.102969_b0225 article-title: New nitrofurans amenable by isocyanide multicomponent chemistry are active against multidrug-resistant and poly-resistant Mycobacterium tuberculosis publication-title: Bioorg. Med. Chem. doi: 10.1016/j.bmc.2017.02.003 contributor: fullname: Krasavin – volume: 150 start-page: 347 year: 2018 ident: 10.1016/j.bioorg.2019.102969_b0280 article-title: Recent advances of imidazole-containing derivatives as anti-tubercular agents publication-title: Eur. J. Med. Chem. doi: 10.1016/j.ejmech.2018.03.016 contributor: fullname: Fan – volume: 7 start-page: 217 year: 2015 ident: 10.1016/j.bioorg.2019.102969_b0205 article-title: Schiff bases of indoline-2,3-dione (isatin) derivatives as efficient agents against resistant strains of Mycobacterium tuberculosis publication-title: Der. Pharm. Chem. contributor: fullname: Aboul-Fadl – ident: 10.1016/j.bioorg.2019.102969_b0200 – volume: 20 start-page: 6063 year: 2012 ident: 10.1016/j.bioorg.2019.102969_b0130 article-title: Antitubercular nitrofuran isoxazolines with improved pharmacokinetic properties publication-title: Bioorg. Med. Chem. doi: 10.1016/j.bmc.2012.08.023 contributor: fullname: Rakesh – volume: 23 start-page: 6842 year: 2013 ident: 10.1016/j.bioorg.2019.102969_b0195 article-title: Anti-tubercular Agents. Part 8: synthesis, antibacterial and antitubercular activity of 5-nitrofuran based 1,2,3-triazoles publication-title: Bioorg. Med. Chem. Lett. doi: 10.1016/j.bmcl.2013.10.010 contributor: fullname: Kamal – ident: 10.1016/j.bioorg.2019.102969_b0020 – volume: 6 start-page: 354 year: 2017 ident: 10.1016/j.bioorg.2019.102969_b0305 article-title: A review on quinoline hydrazone derivatives as a new class of potent antitubercular and anticancer agents publication-title: Beni-Suef Univ. J. Basic Appl. Sci. doi: 10.1016/j.bjbas.2017.07.005 contributor: fullname: Mandewale – ident: 10.1016/j.bioorg.2019.102969_b0015 – volume: 138 start-page: 66 year: 2017 ident: 10.1016/j.bioorg.2019.102969_b0230 article-title: Azide-alkyne cycloaddition towards 1H–1,2,3-triazole tethered Gatifloxacin and Isatin conjugates: design, synthesis and in vitro anti-mycobacterial evaluation publication-title: Eur. J. Med. Chem. doi: 10.1016/j.ejmech.2017.05.057 contributor: fullname: Xu – volume: 6 start-page: 170 year: 2015 ident: 10.1016/j.bioorg.2019.102969_b0045 article-title: Bedaquiline for the treatment of multidrug-resistant tuberculosis: great promise or disappointment? publication-title: Ther. Adv. Chronic. Dis. doi: 10.1177/2040622315582325 contributor: fullname: Field – ident: 10.1016/j.bioorg.2019.102969_b0030 – volume: 9 start-page: e87909 year: 2014 ident: 10.1016/j.bioorg.2019.102969_b0120 article-title: Pentacyclic nitrofurans with in vivo efficacy and activity against nonreplicating Mycobacterium Tuberculosis publication-title: PLoS ONE doi: 10.1371/journal.pone.0087909 contributor: fullname: Rakesh – volume: 5 start-page: 251 year: 2012 ident: 10.1016/j.bioorg.2019.102969_b0255 article-title: Synthesis, evaluation and QSAR analysis of 5-nitrofuran-2-yl/4-nitrophenyl methylene substituted hydrazides as antitubercular agents publication-title: Asian J. Pharm. Clin. Res. contributor: fullname: Gupta – volume: 47 start-page: 5276 year: 2004 ident: 10.1016/j.bioorg.2019.102969_b0110 article-title: Synthesis of nitrofuranyl amides as novel antituberculosis agents publication-title: J. Med. Chem. doi: 10.1021/jm049972y contributor: fullname: Tangallapally – ident: 10.1016/j.bioorg.2019.102969_b0025 – volume: 45 start-page: 3407 year: 2010 ident: 10.1016/j.bioorg.2019.102969_b0245 article-title: Synthesis and in vitro antimycobacterial activity of balofloxacin-ethylene-isatin derivatives publication-title: Eur. J. Med. Chem. doi: 10.1016/j.ejmech.2010.04.027 contributor: fullname: Feng – volume: 47 start-page: 2685 year: 2003 ident: 10.1016/j.bioorg.2019.102969_b0070 article-title: Thiosemicarbazole (thiacetazone-like) compound with activity against Mycobacterium Avium in Mice publication-title: Antimicrob. Agents Chemother. doi: 10.1128/AAC.47.8.2685-2687.2003 contributor: fullname: Bermudez – volume: 70 start-page: 2456 year: 2015 ident: 10.1016/j.bioorg.2019.102969_b0165 publication-title: J. Antimicrob. Chemother. doi: 10.1093/jac/dkv147 contributor: fullname: Huttner – ident: 10.1016/j.bioorg.2019.102969_b0100 – volume: 20 start-page: 4313 year: 2010 ident: 10.1016/j.bioorg.2019.102969_b0180 article-title: 5-Nitro-2-furoic acid hydrazones: design, synthesis and in vitro antimycobacterial evaluation against log and starved phase cultures publication-title: Bioorg. Med. Chem. Lett. doi: 10.1016/j.bmcl.2010.06.096 contributor: fullname: Sriram – volume: 28 start-page: 3064 year: 2018 ident: 10.1016/j.bioorg.2019.102969_b0250 article-title: Design, synthesis and evaluation of oxime-functionalized nitrofuranylamides as novel antitubercular agents publication-title: Bioorg. Med. Chem. Lett. doi: 10.1016/j.bmcl.2018.07.046 contributor: fullname: Fana – volume: 16 start-page: 2584 year: 2006 ident: 10.1016/j.bioorg.2019.102969_b0115 article-title: Discovery of novel isoxazolines as anti-tuberculosis agents publication-title: Bioorg. Med. Chem. Lett. doi: 10.1016/j.bmcl.2006.02.048 contributor: fullname: Tangallapally – volume: 45 start-page: 3407 year: 2010 ident: 10.1016/j.bioorg.2019.102969_b0050 article-title: Synthesis and in vitro antimycobacterial activity of balofloxacin ethylene isatin derivatives publication-title: Eur. J. Med. Chem. doi: 10.1016/j.ejmech.2010.04.027 contributor: fullname: Feng – volume: 38 start-page: 1617 year: 2015 ident: 10.1016/j.bioorg.2019.102969_b0210 article-title: Synthesis, in vitro and in silico studies of some novel 5-nitrofuran-2-yl hydrazones as antimicrobial and antitubercular agents publication-title: Biol. Pharm. Bull. doi: 10.1248/bpb.b15-00439 contributor: fullname: Abdel-Aziz – volume: 54 start-page: 579 year: 2012 ident: 10.1016/j.bioorg.2019.102969_b0035 article-title: Totally drug-resistant tuberculosis in India publication-title: Clin. Infect. Dis. doi: 10.1093/cid/cir889 contributor: fullname: Udwadia – volume: 9 start-page: 180 year: 2013 ident: 10.1016/j.bioorg.2019.102969_b0075 article-title: Some recent approaches in the design of synthetic anti-tubercular agents containing five membered heterocycles rings publication-title: OCAIJ contributor: fullname: Asif – volume: 48 start-page: 8261 year: 2005 ident: 10.1016/j.bioorg.2019.102969_b0105 article-title: Synthesis and evaluation of cyclic secondary amine substituted phenyl and benzyl nitrofuranyl amides as novel antituberculosis agents publication-title: J. Med. Chem. doi: 10.1021/jm050765n contributor: fullname: Tangallapally – volume: 20 start-page: 6063 year: 2012 ident: 10.1016/j.bioorg.2019.102969_b0290 article-title: Antitubercular nitrofuran isoxazolines with improved pharmacokinetic properties publication-title: Bioorg. Med. Chem. doi: 10.1016/j.bmc.2012.08.023 contributor: fullname: Rakesh – year: 2015 ident: 10.1016/j.bioorg.2019.102969_b0085 article-title: Synthesis, and structure-activity relationship for C(4) and/or C(5) thienyl substituted pyrimidines, as a new family of antimycobacterial compounds publication-title: Eu. J. Med. Chem doi: 10.1016/j.ejmech.2015.05.007 contributor: fullname: Verbitskiy – volume: 65 start-page: 455 year: 2012 ident: 10.1016/j.bioorg.2019.102969_b0310 article-title: Finding a new potential antimycobacterium derivative in a aldehyde–arylhydrazone–oxoquinoline series publication-title: Curr. Microbiol. doi: 10.1007/s00284-012-0176-6 contributor: fullname: Santos – volume: 26 start-page: 3669 year: 2016 ident: 10.1016/j.bioorg.2019.102969_b0220 article-title: Identification of novel 2-aminothiazole conjugated nitrofuran as antitubercular and antibacterial agents publication-title: Bioorg. Med. Chem. Lett. doi: 10.1016/j.bmcl.2016.05.088 contributor: fullname: Ran – ident: 10.1016/j.bioorg.2019.102969_b0060 – volume: 7 start-page: 509 year: 2007 ident: 10.1016/j.bioorg.2019.102969_b0140 article-title: Nitrofurans as novel anti-tuberculosis agents: identification, development and evaluation publication-title: Curr. Top. Med. Chem. doi: 10.2174/156802607780059772 contributor: fullname: Tangallapally – volume: 19 start-page: 1152 year: 2009 ident: 10.1016/j.bioorg.2019.102969_b0170 article-title: 5-Nitrofuran-2-yl derivatives: synthesis and inhibitory activities against growing and dormant mycobacterium species publication-title: Bioorg. Med. Chem. Lett. doi: 10.1016/j.bmcl.2008.12.088 contributor: fullname: Sriram |
| SSID | ssj0011476 |
| Score | 2.3570237 |
| SecondaryResourceType | review_article |
| Snippet | [Display omitted]
Pulmonary tuberculosis (TB) is an infectious disease caused by Mycobacterium tuberculosis (MTB) and still remains one of the foremost fatal... Pulmonary tuberculosis (TB) is an infectious disease caused by Mycobacterium tuberculosis (MTB) and still remains one of the foremost fatal infectious... |
| SourceID | proquest crossref pubmed elsevier |
| SourceType | Aggregation Database Index Database Publisher |
| StartPage | 102969 |
| SubjectTerms | 5-Nitrofuran Structure-Activity Relationships (SARs) Tuberculosis (TB) |
| Title | Current development of 5-nitrofuran-2-yl derivatives as antitubercular agents |
| URI | https://dx.doi.org/10.1016/j.bioorg.2019.102969 https://www.ncbi.nlm.nih.gov/pubmed/31077910 https://search.proquest.com/docview/2231928150 |
| Volume | 88 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dS8MwED-GPuiL6ObH_CKC-Bbt2rRdH8dQ5seGiIJvIVkTmWg79iHsxb_du7RVBEUQCqXh2oZLevdL73cXgOOhtiH63TZXsQpwgWI1bxsdc-OnYUr114ymBOf-IOo9iKvH8LEG3SoXhmiVpe0vbLqz1mXLWanNs_FoRDm-IvS9CF1aQOEuSjTHBvo4T98_aR4I990GcyTMSbpKn3McLz3K88kTEbwSqmGQEO35Z_f0G_x0buhiHdZK_Mg6RRc3oGayOjQ6Ga6dXxfshDlGp_tVXoeVbrWbWwP6ZSEmln6xhFhuWcjxm0ZbPEefxX2-eEGBidvx7M1MmcKD8njn2kwcYZUpSsWabsLDxfl9t8fLrRT4ED3UjFM0MwlCobx0GKZKUbDNV7EIE8-YKEI3rrT1k3YUGaOFbbW1Etb6aeAHSonEBluwlOWZ2QFm0pYSMQoEwohWmihc4OlWFA-VZ_F5URN4pUE5LipmyIpK9iwLjUvSuCw03oS4UrP8NvISjfofdx5VoyJRmxTpUJnJ51OJmAeRK84JrwnbxXB99gXxbBwjSNr993v3YJWuCtLuPizNJnNzgNBkpg_d3DuE5U737uaWzpfXvcEHAfrkrw |
| link.rule.ids | 315,786,790,4521,24144,27957,27958,45620,45714 |
| linkProvider | Elsevier |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8QwEB50PehFfLs-I4i3YB9Jsz0ui7I-dk8K3kKyTWRFW9mH4L93pg9FUAShpzZpwySd-ZL5ZgbgdGS9RLvb4UaZGDco3vKOs4q7KJMZ5V9zlgKcB8Okfy-uH-TDAvSaWBiiVda6v9Lppbau75zX0jx_HY8pxlfIKEjQpMXk7pKLsCSkCkULlrpXN_3hpzMhFGWNOWrPqUMTQVfSvOy4KCaPxPFKKY1BSsznny3Ubwi0tESXa7BaQ0jWrUa5Dgsu34DNbo7b55d3dsZKUmd5Wr4By72moNsmDOpcTCz7IgqxwjPJ8bdGdTxHs8Uj_v6MDSZl0bM3N2UGLwrlnVs3KTmrzFA01nQL7i8v7np9XldT4CM0UjNODs00lsIE2UhmxpC_LTJKyDRwLknQkhvro7STJM5Z4cOONcL7KIuj2BiR-ngbWnmRu11gLguNUNggFk6EWWpwj2fDRI1M4PF9SRt4I0H9WiXN0A2b7ElXEtckcV1JvA2qEbP-Nvka9fofPU-aWdEoTXJ2mNwV86lG2IPgFZdF0Iadaro-x4KQVinESXv__u4xLPfvBrf69mp4sw8r9KTi8B5AazaZu0NEKjN7VK_ED8Iy5dA |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Current+development+of+5-nitrofuran-2-yl+derivatives+as+antitubercular+agents&rft.jtitle=Bioorganic+chemistry&rft.au=Elsaman%2C+Tilal&rft.au=Mohamed%2C+Malik+Suliman&rft.au=Mohamed%2C+Magdi+A.&rft.date=2019-07-01&rft.issn=0045-2068&rft.volume=88&rft.spage=102969&rft_id=info:doi/10.1016%2Fj.bioorg.2019.102969&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_bioorg_2019_102969 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0045-2068&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0045-2068&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0045-2068&client=summon |